Brecon opens new facility citing 2011 partnership as driver

By Gareth Macdonald

- Last updated on GMT

Brecon Pharmaceuticals has opened a new storage facility for clinical trial supplies citing higher demand following its partnership with Anderson.

The Powys, Wales-based contract packaging and clinical trial services group – which is part of US group AmeriSourceBergen – opened the facility in Treforest earlier this month adding 23,000 sq ft of temperature controlled storage capacity.

The site – which created eight new jobs – has space for 1000 ambient pallets, 160 refrigerated pallets and 50 frozen pallets and is intended to provide distribution services for both clinical trial supplies and commercial products.

Managing director Peter Belden told Outsourcing-pharma.com the formation of Brecon’s partnership with Anderson Packaging​ – which is also owned by AmerisourceBergen and part of ABCS – prompted the expansion and had created opportunities in the UK and beyond.

Since the creation of Anderson Brecon Clinical Services (ABCS) in the UK, there has been much greater demand for clinical trial support services.

The new site will enable Brecon Pharmaceuticals to meet the growing needs of its customers and as a result, will create more opportunities for the industry across the UK and the rest of Europe.”

Brecon and Anderson became part of AmbersourceBegren’s consulting services (ABCS) segment - which ships trial supplies and approved drugs - last year when the US services firm decided to rearranged its contract packaging and distribution services division.

UK trial services hub

The opening of the new Brecon facility took place just a few days before Catalent completed its acquisition of Aptuit’s trial supplies business​, which added two UK distribution centres to the New Jersey contractor’s global network.

And, the Brecon opening followed a few weeks after Northern Ireland, UK-based contractor Almac opened a new clinical supply services facility in Craigavon​.

All of which suggests that the UK is likely to maintain its position as a key trial supply distribution hub and that competition among service providers will increase.

Related news

Related products

show more

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Unlock potential in buffer preparation

Unlock potential in buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Sep-2023 | Infographic

Consider how the right partner can help you scale faster, mitigate risks, and optimize resources.

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 14-Aug-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Designing an Optimal APAC Clinical Supply Chain

Designing an Optimal APAC Clinical Supply Chain

Content provided by Catalent | 08-Mar-2023 | Infographic

With clinical study activity increasing across the Asia-Pacific region, it is important for sponsors—both in APAC and globally—to understand the broader...

Follow us

Products

View more

Webinars